Citations

Clear

56 citation(s) found for "Lee, Nancy".

Lack of Eosinophil Peroxidase or Major Basic Protein Impairs Defense against Murine Filarial Infection
Specht, Sabine , Saeftel, Michael, Arndt, Manuela, Endl, Elmar, Dubben, Bettina, Lee, Nancy A., Lee, James J. , Hoerauf, Achim M.

Mayo Clinic

Infection and Immunity | August 22, 2006 | Volume: 74 | Issue: 9 | Pages: 5236-5243

10.1128/iai.00329-06 | PMID 16926417 Get It

ABSTRACTEosinophils are a hallmark of allergic diseases and helminth infection, yet direct evidence for killing of helminth parasites by their toxic granule products exists only in vitro. We investigated the in vivo roles of the eosinophil granule proteins eosinophil peroxidase (EPO) and major basic protein 1 (MBP) during infection with the rodent filariaLitomosoides sigmodontis. Mice deficient for either EPO or MBP on the 129/SvJ background developed significantly higher worm burdens than wild-type mice. Furthermore, the data indicate that EPO or MBP is involved in modulating the immune response leading to altered cytokine production during infection. Thus, in the absence of MBP, mice showed increased interleukin-10 (IL-10) production after stimulation of macrophages from the thoracic cavity where the worms reside. In addition to elevated IL-10 levels, EPO−/−mice displayed strongly increased amounts of the Th2 cytokine IL-5 by CD4 T cells as well as a significantly higher eosinophilia. Interestingly, a reduced ability to produce IL-4 in the knockout strains could even be seen in noninfected mice, arguing for different innate propensities to react with a Th2 response in the absence of either EPO or MBP. In conclusion, both of the eosinophil granule products MBP and EPO are part of the defense mechanism against filarial parasites. These data suggest a hitherto unknown interaction between eosinophil granule proteins, defense against filarial nematodes, and cytokine responses of macrophages and CD4 T cells.
Schistosoma mansoni infection in eosinophil lineage–ablated mice
Swartz, Jonathan M. , Dyer, Kimberly D., Cheever, Allen W., Ramalingam, Thirumalai R. , Pesnicak, Lesley, Domachowske, Joseph B. , Lee, James J. , Lee, Nancy A., Foster, Paul S. , Wynn, Thomas A. , Rosenberg, Helene F.

Mayo Clinic

Blood | June 14, 2006 | Volume: 108 | Issue: 7 | Pages: 2420-2427

10.1182/blood-2006-04-015933 | PMID 16772607 Get It

AbstractWe explore the controversial issue of the role of eosinophils in host defense against helminthic parasites using the established Schistosoma mansoni infection model in 2 novel mouse models of eosinophil lineage ablation (ΔdblGATA and TgPHIL). No eosinophils were detected in bone marrow of infected ΔdblGATA or TgPHIL mice, despite the fact that serum IL-5 levels in these infected mice exceeded those in infected wild type by approximately 4-fold. Liver granulomata from infected ΔdblGATA and TgPHIL mice were likewise depleted of eosinophils compared with those from their respective wild types. No eosinophil-dependent differences in granuloma number, size, or fibrosis were detected at weeks 8 or 12 of infection, and differential accumulation of mast cells was observed among the ΔdblGATA mice only at week 12. Likewise, serum levels of liver transaminases, alanine aminotransferase (ALT), and aspartate aminotransferase (AST) increased in all mice in response to S mansoni infection, with no eosinophil-dependent differences in hepatocellular damage observed. Finally, eosinophil ablation had no effect on worm burden or on egg deposition. Overall, our data indicate that eosinophil ablation has no impact on traditional measures of disease in the S mansoni infection model in mice. However, eosinophils may have unexplored immunomodulatory contributions to this disease process.
Pivotal Advance: Eosinophil infiltration of solid tumors is an early and persistent inflammatory host response
Cormier, Stephania A. , Taranova, Anna G. , Bedient, Carrie E., Protheroe, Cheryl, Pero, Ralph, Dimina, Dawn, Ochkur, Sergei I. , O'Neill, K.R. , Colbert, Dana, Lombari, Theresa R, Constant, Stephanie L., McGarry, Michael P. , Lee, James J. , Lee, Nancy A., Nguyen, Thanh D.

Mayo Clinic

Journal of Leukocyte Biology | April 14, 2006 | Volume: 79 | Issue: 6 | Pages: 1131-1139

10.1189/jlb.0106027 | PMID 16617160 Get It

Abstract Tumor-associated eosinophilia has been observed in numerous human cancers and several tumor models in animals; however, the details surrounding this eosinophilia remain largely undefined and anecdotal. We used a B16-F10 melanoma cell injection model to demonstrate that eosinophil infiltration of tumors occurred from the earliest palpable stages with significant accumulations only in the necrotic and capsule regions. Furthermore, the presence of diffuse extracellular matrix staining for eosinophil major basic protein was restricted to the necrotic areas of tumors, indicating that eosinophil degranulation was limited to this region. Antibody-mediated depletion of CD4+ T cells and adoptive transfer of eosinophils suggested, respectively, that the accumulation of eosinophils is not associated with T helper cell type 2-dependent immune responses and that recruitment is a dynamic, ongoing process, occurring throughout tumor growth. Ex vivo migration studies have identified what appears to be a novel chemotactic factor(s) released by stressed/dying melanoma cells, suggesting that the accumulation of eosinophils in tumors occurs, in part, through a unique mechanism dependent on a signal(s) released from areas of necrosis. Collectively, these studies demonstrate that the infiltration of tumors by eosinophils is an early and persistent response that is spatial-restricted. It is more important that these data also show that the mechanism(s) that elicit this host response occur, independent of immune surveillance, suggesting that eosinophils are part of an early inflammatory reaction at the site of tumorigenesis.
Defining a Link with Asthma in Mice Congenitally Deficient in Eosinophils
Lee, James J. , Dimina, Dawn, Macias, MiMi P., Ochkur, Sergei I. , McGarry, Michael P. , O'Neill, K.R. , Protheroe, Cheryl, Pero, Ralph, Cormier, Stephania A. , Lenkiewicz, Elizabeth, Colbert, Dana, Ackerman, Steven J. , Irvin, Charles G. , Lee, Nancy A., Nguyen, Duc Thanh , Rinaldi, Lisa

Mayo Clinic

Science | September 16, 2004 | Volume: 305 | Issue: 5691 | Pages: 1773-1776

10.1126/science.1099472 | PMID 15375267 Get It

Eosinophils are often dominant inflammatory cells present in the lungs of asthma patients. Nonetheless, the role of these leukocytes remains poorly understood. We have created a transgenic line of mice (PHIL) that are specifically devoid of eosinophils, but otherwise have a full complement of hematopoietically derived cells. Allergen challenge of PHIL mice demonstrated that eosinophils were required for pulmonary mucus accumulation and the airway hyperresponsiveness associated with asthma. The development of an eosinophil-less mouse now permits an unambiguous assessment of a number of human diseases that have been linked to this granulocyte, including allergic diseases, parasite infections, and tumorigenesis.
Eosinophil degranulation in the allergic lung of mice primarily occurs in the airway lumen
Simson, Ljubov, Newcombe, Nicole R., Koskinen, Aulikki, Mattes, Joërg , Lee, Nancy A., Lee, James J. , Dent, Lindsay A. , Matthaei, Klaus I., Foster, Paul S. , Clark, Kristopher

Mayo Clinic

Journal of Leukocyte Biology | March 16, 2004 | Volume: 75 | Issue: 6 | Pages: 1001-1009

10.1189/jlb.0803391 | PMID 15020648 Get It

AbstractEosinophil degranulation is thought to play a pivotal role in the pathogenesis of allergic disorders. Although mouse models of allergic disorders have been used extensively to identify the contribution of eosinophils to disease, ultrastructural evidence of active granule disassembly has not been reported. In this investigation, we characterized the degree of eosinophil activation in the bone marrow, blood, lung tissue, and airways lumen [bronchoalveolar lavage fluid (BALF)] of ovalbumin-sensitized and aero-challenged wild-type and interleukin-5 transgenic mice. Degranulation was most prominent in and primarily compartmentalized to the airways lumen. Eosinophils released granule proteins by the process of piecemeal degranulation (PMD). Accordingly, recruitment and activation of eosinophils in the lung correlated with the detection of cell-free eosinophil peroxidase in BALF and with the induction of airways hyper-reactivity. As in previous studies with human eosinophils, degranulation of isolated mouse cells did not occur until after adherence to extracellular matrix. However, higher concentrations of exogenous stimuli appear to be required to trigger adherence and degranulation (piecemeal) of mouse eosinophils when compared with values reported for studies of human eosinophils. Thus, mouse eosinophils undergo PMD during allergic inflammation, and in turn, this process may contribute to pathogenesis. However, the degranulation process in the allergic lung of mice is primarily compartmentalized to the airway lumen. Understanding the mechanism of eosinophil degranulation in the airway lumen may provide important insights into how this process occurs in human respiratory diseases.
Interleukin-5 Expression in the Lung Epithelium of Transgenic Mice Leads to Pulmonary Changes Pathognomonic of Asthma
Lee, James J. , McGarry, Michael P. , Farmer, Steven C., Denzler, Karen L., Larson, Kirsten A., Carrigan, Patricia E., Brenneise, Ina E., Horton, Margaret A., Haczku, Angela , Gelfand, Erwin W. , Leikauf, George D. , Lee, Nancy A.

Mayo Clinic

The Journal of Experimental Medicine | July 26, 2002 | Volume: 185 | Issue: 12 | Pages: 2143-2156

10.1084/jem.185.12.2143 | PMID 9182686 Get It

We have generated transgenic mice that constitutively express murine interleukin (IL)-5 in the lung epithelium. Airway expression of this cytokine resulted in a dramatic accumulation of peribronchial eosinophils and striking pathologic changes including the expansion of bronchusassociated lymphoid tissue (BALT), goblet cell hyperplasia, epithelial hypertrophy, and focal collagen deposition. These changes were also accompanied by eosinophil infiltration of the airway lumen. In addition, transgenic animals displayed airway hyperresponsiveness to methacholine in the absence of aerosolized antigen challenge. These findings demonstrate that lung-specific IL-5 expression can induce pathologic changes characteristic of asthma and may provide useful models to evaluate the efficacy of potential respiratory disease therapies or pharmaceuticals.